Article Information
History
- March 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nozomi Fukui, MPH1,2,†,
- Sophia S. Li, BS1,3,†,
- Jennifer DeGuzman, MPH1,
- Jennifer F. Myers, MPH1,
- John Openshaw, MD1,
- Anjali Sharma, ScD4,5,
- James Watt, MD, MPH1,
- Joseph A. Lewnard, PhD2,6,7,
- Seema Jain, MD1,
- Kristin L. Andrejko, PhD1,2,†,#,
- Jake M. Pry, PhD, MPH1,8,†,#,
- the California COVID-19 Case-Control Study Team1,§
- 1California Department of Public Health, Richmond, CA, USA
- 2Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, USA
- 3College of Agricultural and Environmental Sciences, University of California, Davis, CA, USA
- 4University of Washington, Hans Rosling Center, Global Health, Seattle, WA
- 5The Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia
- 6Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, California, USA
- 7Center for Computational Biology, College of Engineering, University of California, Berkeley, California, USA
- 8Department of Public Health Sciences, School of Medicine, University of California, Davis, California, USA
- ↵#Corresponding Author(s): Jake M. Pry, PhD, MPH, 850 Marina Bay Parkway, Richmond, California 94804, Kristin L. Andrejko, PhD, 850 Marina Bay Parkway, Richmond, California 94804 jmpry{at}ucdavis.edu
↵† Contributed equally to the study